World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
60
Citations
11315
World Ranking
3876
National Ranking
1763

Best Publications

  • Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.

    David Herman;Kai Jenssen;Ryan Burnett;Elisabetta Soragni

  • Clinical features and molecular genetics of autosomal recessive cerebellar ataxias

    Brent L Fogel;Susan Perlman

  • Mortality in Friedreich Ataxia

    Amy Y. Tsou;Erin K. Paulsen;Sarah J. Lagedrost;Susan L. Perlman

  • Spinocerebellar ataxia type 6: Gaze‐evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset

    Christopher M. Gomez;Randall M. Thompson;Jason T. Gammack;Susan L. Perlman

  • Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.

    George Bartzokis;Po H. Lu;Todd A. Tishler;Sophia M. Fong

  • A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.

    David R. Lynch;Susan L. Perlman;Thomas Meier

  • Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS

    Haloom Rafehi;Haloom Rafehi;David J. Szmulewicz;Mark F. Bennett;Mark F. Bennett;Nara L.M. Sobreira

  • Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).

    David R Lynch;Melanie P Chin;Martin B Delatycki;S H Subramony

  • Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.

    Brent L. Fogel;Hane Lee;Joshua L. Deignan;Samuel P. Strom

  • Measuring Friedreich ataxia Complementary features of examination and performance measures

    D. R. Lynch;J. M. Farmer;A. Y. Tsou;S. Perlman

  • Initial experience in the treatment of inherited mitochondrial disease with EPI-743

    Gregory M. Enns;Stephen L. Kinsman;Susan L. Perlman;Kenneth M. Spicer

  • Ataxia-telangiectasia: diagnosis and treatment.

    Susan Perlman;Sara Becker-Catania;Richard A Gatti

  • Spinocerebellar ataxia type 6: Frequency of the mutation and genotype-phenotype correlations

    D. H. Geschwind;S. Perlman;K. P. Figueroa;J. Karrim

  • Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.

    L. P W Ranum;J. K. Lundgren;L. J. Schut;M. J. Ahrens

  • Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia

    David R. Lynch;Jennifer Farmer;Lauren Hauser;Ian A. Blair

  • Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients.

    John S. Child;Joseph K. Perloff;Philip M. Bach;Allan D. Wolfe

  • Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; A prospective observational study

    Tetsuo Ashizawa;Karla P Figueroa;Susan L Perlman;Christopher M Gomez

  • Progression of Friedreich ataxia: quantitative characterization over 5 years.

    Maya Patel;Charles J. Isaacs;Lauren Seyer;Karlla Brigatti

  • Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)

    Sarah J. Lagedrost;Sarah J. Lagedrost;Martin St. John Sutton;Meryl S. Cohen;Meryl S. Cohen;Gary M. Satou

  • α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy

    Suman Dutta;Simon Hornung;Simon Hornung;Adira Kruayatidee;Katherine N. Maina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles